Objective: Tissue inhibitor of metalloproteinase 3 (TIMP3) is an extracellular matrix (ECM) bound protein, which has been shown to be downregulated in human subjects and experimental models with cardiometabolic disorders, including type 2 diabetes mellitus, hypertension and atherosclerosis. The aim of this study was to investigate the effects of TIMP3 on cardiac energy homeostasis during increased metabolic stress conditions. Methods: ApoE À/À TIMP3 À/À and ApoE À/À mice on a C57BL/6 background were subjected to telemetric ECG analysis and experimental myocardial infarction as models of cardiac stress induction. We used Western blot, qRT-PCR, histology, metabolomics, RNA-sequencing and in vivo phenotypical analysis to investigate the molecular mechanisms of altered cardiac energy metabolism.
INTRODUCTION
Chronic heart diseases lead to cardiac remodeling, a phenomenon that, besides structural changes, results in an impaired ability of cardiac myocytes to shift between nutrient substrate usage in order to adapt to energetic needs [1] . Several cellular fuel gauges such as AMPK have been found to contribute to the regulation of synchronicity between tissue function and metabolic fluxes in the heart [1] . However, studies from other systems suggest that the extracellular matrix (ECM) may also participate in the regulation of intracellular metabolism [2] . The ECM may be relevant in different chronic heart diseases [3] , but how its components interact with intracellular signaling pathways to facilitate dynamic changes in heart metabolism is unknown. We have recently focused on Tissue inhibitor of Metalloproteinase 3 (TIMP3), an ECM-bound protein, modulating metalloprotease and angiogenic receptors that is downregulated in human subjects and experimental models with metabolic and inflammatory disorders such as type 2 diabetes mellitus, atherosclerosis and heart failure [4e12].
TIMP3 blocks the release of TNF-alpha and EGFR ligands (including TGF-alpha, amphiregulin) mediated by ADAM17. TIMP3 also blocks the activity of metalloproteases such as MMP9 and MMP14, which play a role in progression of heart disease. Finally, TIMP3 blocks the activation of VEGRF2 with a final effect to stabilize the angiogenic process to obtain a mature tube stabilization [13e16] . Previous work showed that loss of TIMP3 accelerates cardiovascular disorders including dilated and hypertrophic cardiomyopathies, abdominal aortic aneurysm and hypertension related vessel remodeling [17, 18] mediated by TNF-alpha, Angiotensin II and metalloproteases. Functional re-expression of TIMP3 via cell-based, vector delivery, or intravenous administration proved a protective role for TIMP3 against complications of myocardial infarction such as cardiac rupture, ischemic related cardiomyopathy and heart fibrosis and pressure overload, suggesting a putative therapeutic role for this protein to preserve tissue integrity, in part via its ability to maintain vasculature structure and mesenchymal stem cell functions [19e21] . The role of TIMP3 in the context of cardiovascular remodeling is relatively unexplored when considering classical risk factors such as hypercholesterolemia, diabetes and hypertension. We have observed that increased levels of TIMP3 released from inflammatory cells partially protect from atherosclerosis progression in a combined genetic and dietetic model, the low density lipoprotein receptor knockout (LDLR À/À ) mice fed a western diet [10] . Observational studies in subjects with congestive heart failure suggested that TIMP3 might be deficient in the myocardial tissues [22] . We recently described increased atherosclerosis at the aortic level in the ApoE À/À TIMP3
À/À mouse model. Here, we demonstrate that ApoE À/À TIMP3 À/À mice show decreased lifespan at the baseline and a reduced resistance to cardiac stress. To investigate this phenotype in more depth, we combined genetics, metabolomics and in vivo phenotypical analysis. Collectively, metabolite profiling and gene and protein expression consistently suggested that the loss of TIMP3 leads to a perturbation of metabolic flexibility in the heart and arrhythmias, phenomena that may underlie the increased rates of cardiovascular death in this model independently from its atherosclerotic background.
MATERIALS AND METHODS

Experimental animal procedures and metabolic tests
All animal procedures were performed in accordance to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85e23, revised 1996), approved by the University Hospital of Tor Vergata Animal Care Facility and previously described [23] . ApoE À/À TIMP3 À/À mice have previously been described [24] . The genotype was confirmed also assaying TIMP3 protein levels and activity of its substrate Matrix Metalloproteinase 9 (Supplementary Figure S1A- 
Apelin supplementation
For apelin supplementation studies, Pyr-13 apelin was purchased from DBA Italia and resuspended in PBS. For intraperitoneal injections, a concentration of 0.1 mmol/kg was used as previously described [27] .
Control animals received matched volumes of PBS alone.
Gene expression analysis by qRT-PCR
Total RNA was isolated from liver, heart and muscle using Trizol reagent (Invitrogen Corp, Carlsbad, CA). Two micrograms of total RNA were reverse-transcribed into complementary DNA (cDNA) using the High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA). Quantitative real-time polymerase chain reaction was performed using an ABI PRISM 7700 System and TaqMan reagents (Applied Biosystems). Each reaction was performed in triplicate using standard reaction conditions and results were normalized by b-actin. . E) Reduced systolic (dp/dtmax) and diastolic (dp/dtmin) heart function in ApoE Figure 1C ). Although we cannot measure the occurrence of arrhythmias in this experiment, we did not observe bleeding or other operative complications between the 2 groups. In the few survivors, histological analysis of the ventricle showed extension of the infarction area (p < 0.05, Student's t-test, n ¼ 3e4 per group, Figure 1D ) as well as increased ventricular remodeling and dilatation in the ApoE À/À TIMP3 À/À mice ( Figure 1D ). Invasive cardiac function 4 weeks post LAD ligation revealed reduced systolic and diastolic function in ApoE À/À TIMP3 À/ mice (p < 0.05 for both, Student's ttest, Figure 1E ).
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To gain further insight into structural changes within the heart of ApoE À/À TIMP3 À/À mice leading to arrhythmias and sudden cardiac death, we performed echocardiographic and histological analyses. As expected ApoE À/À TIMP3 À/À mice revealed signs of mild atherosclerosis in both coronary and carotid arteries but no signs of atherothrombosis (Supplementary Figure S2AeB) . Left ventricular function as measured with echocardiography did not differ between the groups (Supplementary Figure S2C) . However, staining of heart sections with Oil Red O revealed focal intracellular accumulation of lipid droplets in the hearts of the ApoE However, because the observed differences in the fasting glucose, we repeated the whole-body indirect calorimetry during 12 consecutive hours of fasting conditions. While no differences were observed in the 0e8 h interval (data not shown), we observed that in the interval from 8 to 12 h of fasting the RER was significantly increased due to significantly reduced lipid oxidation (both p < 0.05, Student's t test, Figure 3D ). Tables S1 and S2 ). In the serum of ApoE À/À TIMP3 À/À mice, we observed complex modulation of pathways linked to oxidative stress as demonstrated by the depletion of ergothioneine, equol sulfate, cysteineglutathione disulfide and oxidized glutathione while 2-hydroxybutyrate and 2-aminobutyrate were increased ( Figure 4A,B) .
mice also showed reductions in long-chain monounsaturated FFAs such as 10-nonadecenoate and 10-heptadecenoate, medium-chain acylcarnitines such as hexanoylcarnitine, medium-chain acyl-glycine (i.e., valerylglycine) and the medium-chain fatty acid marker of betaoxidation, 3-hydroxydecanoate ( Figure 5A,B) . On the other hand, the long-chain acyl-carnitine stearoylcarnitine was significantly elevated in ApoE À/À TIMP3 À/À mice ( Figure 5A,B) . ApoE À/À TIMP3 À/À mice also showed altered sphingolipid metabolism with increased levels of palmitoyl sphingomyelin, stearoyl sphingomyelin, 1-stearoylglycerol and sphingosin that can be in part connected to increased stearoylcarnitine and its derivatives ( Figure 6A,B) . and FoxO1 (Supplementary Table S3 ). In skeletal muscle, no important differences were found (Supplementary Table S3 ). In the hearts of ApoE À/À TIMP3 À/À mice, we found significantly decreased expression of PPARa and its targets SCD1, ACADM and a trend for decreased expression of other enzymes involved in fatty acid oxidation such as ACADL and ACADVL (Table 1) . Interestingly, we also found decreased expression of FoxO1, a regulator of oxidative stress and autophagy, and its targets PDK4, ATG5, ATG8, BECN1, LC3, ULK1 ( Figure S4A and Supplementary   Table S4 ). Among the downregulated transcripts, confirmed after qPCR, we found apelin (Supplementary Figure S4A,B) , which we confirmed to be significantly reduced in heart tissue but not in the epididymal White Adipose Tissue (eWAT), muscle and liver from ApoE À/À TIMP3 À/À mice by quantitative PCR (*p < 0.05, Student's t test, Figure 7A ). Apelin blood levels measured by ELISA were shown to be significantly lower in the ApoE À/À TIMP3 À/À compared with ApoE
littermates (*p < 0.05, Student's t test, Figure 7B ). Figure 7C ) to an extent comparable to PBS-injected ApoE mice, although to a lesser extent (****p < 0.001, one-way ANOVA, Figure 7C ). 
DISCUSSION
The phenotype of the ApoE À/À TIMP3 À/À mice revealed new, unpredicted findings linking TIMP3 to metabolic flexibility in the heart. Although, compared to control ApoE À/À littermates, the ApoE À/À TIMP3 À/À mice showed mild increased atherosclerotic plaques and fatty streaks at the aortic roots and the peripheral aorta, the differences were less consistent in the coronary and carotid arteries. It is possible, therefore, that the causes of sudden death are not linked to plaque instability and a possible metabolic origin of the phenotype cannot be excluded. Previous work on the combined ApoE and high-density lipoprotein receptor SR-BI (SR-BI) double knockout revealed early lethality due to increased coronary atherosclerosis combined with lipid accumulation in the left ventricle [29] . The ApoE À/À TIMP3 À/À mice showed similar globular intracellular lipid accumulation, and when shifted to Western diet, a punctate pattern reminiscent of extracellular lipid deposition [29] . However, differently from the ApoE À/À SR-BI À/À model, the ApoE À/À TIMP3 À/À mice revealed increased lethality at an older age or when subjected to stress conditions like telemetry or experimental myocardial infarction, suggesting that the effect may be partially ageand environment dependent, as already observed with TIMP3 in other cardiovascular models [15, 16] . Metabolomics data allows for a hypothesis that explains the increased susceptibility of ApoE À/À TIMP3 À/À mice to cardiovascular diseases.
First, ApoE À/À TIMP3 À/À mice have defective control of oxidative stress. In particular, they show a state of depletion of dietary antioxidants such as ergothioneine and equol sulfate [30, 31] coupled to the decrease of some indicators of oxidation such as cysteine-glutathione disulfide and oxidized glutathione. Similarly, we found increased concentrations of 2-hydroxybutyrate and 2-aminobutyrate, both being derived from the common precursor alpha-ketobutyrate, the levels of which increase when demand for glutathione is high. Since it has been reported that ischemia induces glutathione depletion via osmotic stress [32] , it is intriguing to hypothesize that TIMP3 deficiency in the heart mimics the effect of modified lipoproteins and oxysterols to provoke an ischemia-like metabolic alterations at the myocardial level although we cannot exclude the involvement of other tissues [33, 34] . Secondly, analysis of sphingolipid metabolism displayed deep perturbations in ApoE À/À TIMP3 À/À mice. Glutathione depletion has been shown to regulate sphingomyelin metabolism [35] , and the loss of an oxidative stress response might be responsible for those alterations. In patients with transient ischemia, and thus increased cardiac stress, increased levels of sphingosine have been found [36] . Further, alterations of sphingolipid metabolism have been reported in rats subjected to LAD ligation [37] and in models of ischemia/reperfusion injury [38, 39] . Although, we could not identify ceramide itself in the metabolomics analysis, it is a crucial intermediate of sphingolipid metabolism ( Figure 6B ) and has been associated with the dysfunction of the human ether-a-go-go related gene (HERG) Kþ channel, which, again, is associated with prolongation of the QT interval and arrhythmias [40] . Therefore, perturbations in sphingolipid metabolism might contribute in increased arrhythmias in the ApoE
Thirdly, the circulating metabolite profiles suggest that in the face of mild insulin resistance, the loss of TIMP3 in the hypercholesterolemic background is characterized by a block of fatty acid oxidation at the stearoyl-CoA level. This may prompt increased rates of glucose oxidation to support energetic demands. Mice with stearoyl-CoA desaturase 1 deficiency reveal a similar phenotype to ApoE À/À TIMP3 À/À mice, with increased myocardial glucose utilization and impaired fatty acid oxidation [41] . The limited gene expression screening that we performed in the liver and the muscle confirmed that in this specific context the defective fatty acid oxidation is more prevalent at the cardiovascular level. Therefore, in a TIMP3 deficient state it appears that the heart may be less efficient at compensating for energetic demands during acute stress. Adult cardiomyocytes produce most energy via fatty acid oxidation (FAO) but retain capacity to readily switch to glucose or other substrate utilization when fatty acid is not available or FAO is compromised [1] . Indeed, when subjecting the myocardium to acute oxidative stress and energy depletion in the model of myocardial infarction, there is an increased mortality, which could be explained by an inability to utilize all metabolic pathways available to produce energy. One may postulate that the lower fasting glucose observed in the ApoE À/À TIMP3 À/À mice results from a switch to glucose oxidation that impairs a further increase energy production thus ultimately leading to cell death. The reduction PPARa and some of its target genes involved in fatty acid oxidation (such as Hadha Hadhb ACADS ACADM ACADVL) might in part explain the phenotype of the ApoE À/À TIMP3 À/À mice. In fact, myocardial lipid accumulation and hypoglycemia also characterize the adult mice lacking PPARa [42] . Similarly to the ApoE Forkhead box protein O1 (FoxO1), which is involved in energy metabolism, but also in autophagy. Coupled with this, its targets ATG5, ATG8, BECN1 and LC3 were also downregulated in ApoE À/À TIMP3 À/À mice. Decreased autophagy has been related to heart failure and this reduction might contribute to the reduced heart function we observed in our model of post-ischemic heart failure [48] . The occurrence of cardiovascular mortality in ApoE À/À TIMP3 À/À mice might reflect a complex interaction between metabolic defects and tissue remodeling consequent to increased inflammation and tissue degeneration. Using whole heart mRNA sequencing and subsequent real-time PCR analysis we revealed apelin as a possible mediator of the metabolic effects by TIMP3. In ApoE À/À TIMP3 À/À mice, we found apelin to be decreased in the circulation as well as downregulated at the myocardial level compared to other sites of expression such as the adipose tissue [49] . Apelin supplementation restored impaired lipid oxidation in ApoE À/À TIMP3 À/À mice. Therefore, our data provide a molecular clue for the molecular phenotype observed in ApoE
Apelin has recently been shown to rescue defects in insulin resistance and FAO possibly via regulation of AMPK signaling [27, 49] . However, whether a long-term administration of Apelin is sufficient to prevent lipid accumulation and which signaling pathways contribute remains to be investigated. The effect of TIMP3 on apelin might also explain decreased heart function in post-ischemic heart failure we observed in the ApoE À/À TIMP3 À/À mice. Patients with left ventricular systolic dysfunction exhibit decreased myocardial apelin expression in the left ventricular wall [50] , and experimental in vivo data link apelin to positive inotropic and regenerative effects in both normal hearts and post-ischemic heart failure [51e54]. We did not test the effects of apelin on experimental myocardial infarction. However, it has previously been shown that in a rat model of post ischemic heart failure, also using the model of LAD ligation, apelin supplementation was able to reduce infarction size [55] . ApoE À/À TIMP3 À/À mice displayed an impaired oxidative stress response. Chronic treatment of mice with apelin attenuated pressureoverload-induced left ventricular hypertrophy, by increasing the oxidative stress response [56] , and decreased ischemia/reperfusion injury by restoring levels of antioxidant defense [57] . Thus, reduced apelin levels found in the ApoE À/À TIMP3 À/À mice may also be responsible in part for other metabolomics findings of our study. Recently, it has been reported that apelin reduces sphingosine kinase 1 activity in cardiac fibroblasts [58] and might therefore increase levels of sphingosine.
Since reduced apelin levels have also been associated with arrhythmias [59, 60] , we hypothesize that reduced apelin may contribute to the pro-arrythmogenic phenotype that we observed in the ApoE À/À TIMP3 À/À model. However, a positive effect of apelin supplementation on arrhythmias in this model remains to be seen. We have previously reported that loss of TIMP3 has a role in the pathogenesis obesity-associated non-alcoholic fatty liver disease (NAFLD) [8] . We did not measure the lipid content of the liver in this study, but the fact that the livers of ApoE À/À TIMP3 À/À mice reveal similar defects in the expression of PPARa and FoxO1 targets, including SCD1, suggests that inter-organs crosstalk might be involved in the phenotype observed. Previous studies have shown that SCD1 deficiency is correlated to diet-induced fatty liver disease. NAFLD has also been linked to increased cardiovascular risk, myocardial remodeling and dysfunction as well as prolongation of QTc interval and thus increased risk of arrhythmias [61] . However, we did not observe alterations in hepatic apelin expression suggesting the involvement of different pathways. Overall, we cannot exclude that part of the phenotype is sustained by a liver to heart axis. Interestingly, metabolomics analysis also revealed an alteration of gut micro biota-derived (host co-) metabolites such as serotonin, N-acetyltryptophan and 3-indoxyl sulfate in the ApoE À/À TIMP3 À/À (Supplementary Table 2 ). TIMP3 has been shown to regulate lymphocyte populations [62] as well as to mediate colonic epithelial barrier disruption through ADAM17 and might, therefore, be involved in shaping the gut microbiota and regulation of gut microbiota/host interactions, leading to altered immune and metabolic processes.
Backhed and colleagues could show that germ-free mice exhibited altered gene expression of enzymes involved in fatty acid oxidation [63] . Therefore, an alteration of the gut microbiota might contribute to the phenotype observed in the ApoE À/À TIMP3 À/À mice. 
CONCLUSION
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Lipid Oxidation Figure 7 : Loss of TIMP3 leads to disrupted apelin secretion from heart while supplementation can correct some of the metabolic abnormalities in the heart. A) Apelin expression by qPCR in heart, muscle, adipose tissue and liver reveals a difference between ApoE À/À TIMP3 À/À and ApoE À/À animals only in the heart (*p < 0.05, one-way ANOVA, n ¼ 5 per group). B) Circulating apelin levels measured by ELISA were also found to be reduced in the ApoE Original article
